Press release
Coronary Artery Disease Market Insights - Assessing Growth Opportunities, Forecasting Trends, and Analyzing Competitive Strategies
Coronary Artery Disease Market
The coronary artery disease market size is expected to see rapid growth in the next few years. It will grow to $42.65 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to growing lifestyle factors, focus on telemedicine and remote monitoring, expansion of interventional cardiology procedures, shift towards value-based healthcare models, development of novel drug therapies.. Major trends in the forecast period include development of gene therapies, integration of artificial intelligence in diagnosis, focus on mental health in cad care, rise in home-based healthcare services, adoption of remote cardiac rehabilitation..
Market Overview -
Coronary artery disease (CAD) is a medical condition that affects the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Coronary artery disease occurs when arteries become narrowed or blocked due to plaque buildup, a substance composed of cholesterol, fat, calcium, and other substances.
Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp
The Influence Of Rising Coronary Artery Disease Prevalence Fuels The Coronary Artery Disease Market
The rise in the prevalence of coronary artery disease is expected to propel the growth of the coronary artery disease market over the coming years. Coronary artery disease (CAD) is a medical condition characterized by the narrowing or blockage of the coronary arteries, which supply blood to the heart muscle. Coronary artery disease cases are increasing due to increased changes in diet, stress, lack of exercise, obesity, age, and others. Coronary artery disease is treated with drugs using clopidogrel, ticagrelor, warfarin, and heparin and with procedures such as coronary artery bypass grafting, angioplasty, and stenting. For instance, in May 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2021, coronary heart disease, the most prevalent form of heart disease, claimed the lives of 375,476 individuals. Approximately 5% of adults aged 20 and above are affected by coronary artery disease (CAD), translating to about 1 in 20 individuals. Therefore, the rise in the prevalence of coronary artery disease is expected to boost the coronary artery disease market during the forecast period.
Competitive Landscape -
Major companies operating in the coronary artery disease market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc. , Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Chiesi Farmaceutici S.p.A., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Honya Medical Inc., Idorsia Pharmaceuticals Ltd., Cytokinetics Inc., Kowa Pharmaceuticals America Inc., Sinotau Pharmaceutical Group, HRV Global Life Sciences, Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz- Kreislauf-Forschung (DZHK) e.V.
Spearhead Ai-Infused Blood Tests For Coronary Artery Disease
Major companies operating in the coronary artery disease market are focusing on developing innovative technologies such as AI-based blood tests. An AI-based blood test refers to a diagnostic test that incorporates artificial intelligence (AI) algorithms in the analysis and interpretation of blood-related data. For instance, in February 2023, Cardio Diagnostics Holdings, a US-based AI-based integrated genetic-epigenetic engine manufacturing company, announced the launch of PrecisionCHD. Its a combined genetic and epigenetic blood test designed for the early identification of coronary heart disease. PrecisionCHD exhibits over 75% sensitivity for the detection of coronary heart disease in both men and women. Utilizing a machine-learning model derived from the analysis of billions of genomic and epigenomic data points, the test incorporates epigenetic (DNA methylation) and genetic (single nucleotide polymorphism) biomarkers.
Browse Full Report @
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report
Key Segments -
The coronary artery disease market covered in this report is segmented -
1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments
2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Coronary Artery Disease Market Insights - Assessing Growth Opportunities, Forecasting Trends, and Analyzing Competitive Strategies here
News-ID: 3473021 • Views: …
More Releases from The Business research company
Unveiling Growth Strategies and Competitive Landscape: Navigating the Dynamics o …
The medical coatings market size has grown exponentially in recent years. It will grow from $8.65 billion in 2023 to $10.5 billion in 2024 at a compound annual growth rate (CAGR) of 21.4%. The growth in the historic period can be attributed to infection prevention, biocompatibility, advanced drug delivery, performance enhancement, regulatory compliance:.
The medical coatings market size is expected to see exponential growth in the next…
Malted Wheat Flour Market: Unveiling Opportunities in Brewing and Baking Industr …
The malted wheat flour market size has grown strongly in recent years. It will grow from $37.87 billion in 2023 to $40.08 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increased health awareness, changed consumer preferences, increased consumption of bread and confectionery items, increased demand for beer and bakery-confectionery products, traditional baking.
The…
Low Intensity Sweeteners Market: Insights into Health-Conscious Consumer Prefere …
The low intensity sweeteners market size has grown strongly in recent years. It will grow from $2.02 billion in 2023 to $2.16 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increased health consciousness and demand for low-calorie alternatives, growth in diabetic population and need for sugar substitutes, regulatory support for reduced sugar…
Liquid Feed Market Explores Growth Drivers in Livestock Nutrition Industry with …
The liquid feed market size has grown steadily in recent years. It will grow from $3.86 billion in 2023 to $3.99 billion in 2024 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to increased demand for high-quality livestock and poultry products, convenience and ease of use in animal nutrition, rise in concerns for animal health and…
More Releases for Coronary
Coronary Microcatheters Market 2021 | Detailed Report
The Coronary Microcatheters research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers,…
Intravascular Ultrasound Systems Market(By Product Type - Ivus Consoles, Ivus Ca …
Intravascular Ultrasound Systems (IVUS) is an imaging method with which we can visualize a coronary artery from the inside out. Intravascular Ultrasound Systems are usually designed in such a way that the individual can have a complete view of the coronary artery blockade using a catheter which is attached to an ultrasound probe at one end and the other end is attached to a computerized ultrasound equipment.
The inside out view…
Coronary Stents Market - Competitive Strategies 2025
Global Coronary Stents Market: Snapshot
The market for coronary stents has been gaining significant traction across the world. Technological advancements, increasing burden of CAD, and the rising base of geriatric population are the main factors that have been fueling the demand for coronary stents substantially. Apart from these, the augmenting demand for minimally invasive procedures and the rising number of percutaneous coronary intervention (PCI) procedures are also supplementing to the growth…
Global Coronary Stents Market 2018
Press Release - 28 Feb 2018
Global Research and Development News --
. .
Report Description-
' …
Coronary Stents Market Is Thriving Worldwide
HTF MI published a new industry research that focuses on Coronary Stents market and delivers in-depth market analysis and future prospects of Global Coronary Stents market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. The study is…
Coronary Stent Market Ongoing Outlook 2025
Global Coronary Stent Market: Overview
The alarming rise in the number of cardiovascular diseases has become the primary growth driver for the global coronary stent market. Changing lifestyles that are characterized by high stress levels, alcohol consumption, smoking, and poor choice of food habits have collectively led to questionable heart health for the global market. The World Health Organization states that the cardiovascular diseases have become the leading cause of deaths…
